In 2003, Vio Group, a holding company of Vio, was listed in Hong Kong. In 20 1 1 year, Vio Pharmaceuticals officially joined Tibet Yi Ming Xiya Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Yi Ming Pharmaceuticals") and became a wholly-owned subsidiary.
It is also the research, development and production center of Yi Ming medicine. Completed the strategic transformation of R&D, production and sales integration, which laid a solid foundation for enterprise development.